Cencora Inc

Financials

Cash from operating activities 2.21 B2.67 B2.7 B3.91 B3.48 B3.88 B 3.46 B Cash from investing activities 379.87 M6.14 B368.44 M2.6 B618.1 M4.98 B 4.93 B Cash from financing activities 603.62 M1.95 B1.75 B2.22 B2.33 B2.25 B -916.83 M Free cash flow 1.84 B2.23 B2.21 B3.45 B3 B3.21 B 2.78 B

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

COR

Financials

Cencora Inc

Nouvelles

Dividend Champion, Contender, And Challenger Highlights: Week Of February 22

SAMT: Thematic Rotation ETF Reaches Its Objective, But Lags Key Competitor (NYSEARCA:SAMT)

COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal

Cencora fusionne MWI Animal Health avec Covetrus pour 3,5 milliards de dollars

Cencora to merge MWI Animal Health with Covetrus in $3.5 billion deal

Is the Options Market Predicting a Spike in Cencora Stock?

Cencora finalise une émission d’obligations senior de 3 milliards $

Cencora completes $3 billion senior notes offering

Cencora émet des obligations senior de 3 milliards $ à différentes échéances

Cencora prices $3 billion in senior notes across multiple maturities

Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic

Cencora relève les perspectives de ventes pour 2026 malgré un manque à gagner de revenus au premier trimestre | Benzinga France